Company intelligence / Profile preview
Synchroline
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
Synchroline is a specialized dermocosmetic brand developed and manufactured by the Italian pharmaceutical company General Topics S.r.l. The company focuses on the research, development, and production of advanced dermatological solutions designed to treat various skin conditions such as acne, rosacea, and hyperpigmentation. Synchroline products are characterized by their scientific approach, utilizing patented technologies to ensure high efficacy and skin tolerability. The brand is widely recognized in the European and international markets, often distributed through pharmacies and recommended by dermatologists. Their portfolio includes a wide range of topical treatments that address both aesthetic concerns and pathological skin issues.
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculeTopical formulation
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Beyond the preview
Go deeper on Synchroline.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synchroline.